Hanley Jonathan G
School of Biochemistry, Biomedical Sciences Building, University of Bristol, University Walk, Bristol, BS8 1TD, UK.
Neuropharmacology. 2021 Oct 1;197:108723. doi: 10.1016/j.neuropharm.2021.108723. Epub 2021 Jul 15.
AMPA receptors (AMPARs) are the major excitatory neurotransmitter receptor in the brain, and their expression at synapses is a critical determinant of synaptic transmission and therefore brain function. Synaptic plasticity involves increases or decreases in synaptic strength, caused by changes in the number or subunit-specific subtype of AMPARs expressed at synapses, and resulting in modifications of functional connectivity of neuronal circuits, a process which is thought to underpin learning and the formation or loss of memories. Furthermore, numerous neurological disorders involve dysregulation of excitatory synaptic transmission or aberrant recruitment of plasticity processes. MicroRNAs (miRNAs) repress the translation of target genes by partial complementary base pairing with mRNAs, and are the core component of a mechanism widely used in a range of cell processes for regulating protein translation. MiRNA-dependent translational repression can occur locally in neuronal dendrites, close to synapses, and can also result in relatively rapid changes in protein expression. MiRNAs are therefore well-placed to regulate synaptic plasticity via the local control of AMPAR subunit synthesis, and can also result in synaptic dysfunction in the event of dysregulation in disease. Here, I will review the miRNAs that have been identified as playing a role in physiological or pathological changes in AMPAR subunit expression at synapses, focussing on miRNAs that target mRNAs encoding AMPAR subunits, and on miRNAs that target AMPAR accessory proteins involved in AMPAR trafficking and hence the regulation of AMPAR synaptic localisation. This article is part of the special Issue on 'Glutamate Receptors - AMPA receptors'.
α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPA受体)是大脑中主要的兴奋性神经递质受体,其在突触处的表达是突触传递进而也是脑功能的关键决定因素。突触可塑性涉及突触强度的增加或降低,这是由突触处表达的AMPA受体数量或亚基特异性亚型的变化引起的,导致神经元回路功能连接性的改变,这一过程被认为是学习以及记忆形成或丧失的基础。此外,许多神经系统疾病涉及兴奋性突触传递失调或可塑性过程的异常激活。微小RNA(miRNA)通过与mRNA进行部分互补碱基配对来抑制靶基因的翻译,并且是广泛用于一系列细胞过程中调节蛋白质翻译的机制的核心组成部分。依赖miRNA的翻译抑制可在神经元树突中靠近突触的局部发生,并且还可导致蛋白质表达的相对快速变化。因此,miRNA非常适合通过对AMPA受体亚基合成的局部控制来调节突触可塑性,并且在疾病中失调的情况下也可导致突触功能障碍。在此,我将综述已被确定在突触处AMPA受体亚基表达的生理或病理变化中起作用的miRNA,重点关注靶向编码AMPA受体亚基的mRNA的miRNA,以及靶向参与AMPA受体转运从而调节AMPA受体突触定位的AMPA受体辅助蛋白的miRNA。本文是“谷氨酸受体 - AMPA受体”特刊的一部分。